Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A 24 week, randomised, double blind, parallel study to compare the change in HbA1c with AVANDAMETĀ® (8.0mg / 2.0g) plus insulin to placebo plus insulin, in subjects with type 2 diabetes starting insulin therapy
rosiglitazone/metformin
712753/009
NCT00069836
Diabetes Mellitus, Type 2
Phase 3
 
November 2014

Powered by ideaPoint, Inc.